IMU 1.89% 5.2¢ imugene limited

Ann: Imugene completes Phase 1a trial of immunotherapy PD1-Vaxx, page-2

  1. 2,184 Posts.
    lightbulb Created with Sketch. 660
    Top comment
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.